CEREBROPROTEIN HYDROLYSATE INDUCED SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (SIRS): A CASE REPORT
2016 ◽
Vol 9
(1)
◽
pp. 321
◽
Keyword(s):
<p>Cerebroprotein hydrolysate is a newer pharmacological neurotropic agent and considered as a promising therapeutic agent for dementia, Alzheimer’s disease, traumatic brain injury and acute ischaemic stroke. Studies revealed that most of the side effects are minor. Here, we reported a case of Systemic inflammatory response syndrome (SIRS) probably due to use of Cerebroprotein hydrolysate in a patient with acute ischaemic stroke.</p>
2019 ◽
Vol 40
(5)
◽
pp. 723-724
◽
2016 ◽
Vol 38
(3)
◽
pp. 370
2015 ◽
Vol 271
◽
pp. 409-422
◽
2021 ◽
Vol 25
(8)
◽
pp. 940-942